Helen Ujvary, MSc MSc Oxon Australian Representative Responsible for new business development in Australia, and analytical work and inward/outward transaction support for Australian deals across all sectors. Prior to joining FPG in 2001 and again in 2006, Helen was employed by Quartz (a subsidiary of Knight Securities) from 2000-2001 as a Biotech analyst, specialising in the Genomics, Proteomics, Bioinformatics and Anti-infectives sectors. Prior to joining Quartz, she worked at Seymour Pierce as an equity analyst specialising in the Biotech sector in 1999-2000. MSc in Biotechnology from the University of Kent at Canterbury; MSc (Oxon) in Chemical Engineering from Oxford University.